Navigation Links
Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)
Date:7/10/2014

BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that while more than three-quarters of surveyed infectious disease (ID) specialists are willing to prescribe Durata's Dalvance (dalbavancin) and The Medicines Company's Orbactiv (oritavancin) for use as OPAT, approximately two-thirds of the respondents reported a willingness to prescribe these agents to their hospital inpatients. However, our findings indicate that nearly two-thirds (64 percent) of OPAT patients are initiated on OPAT following hospital discharge, and most are discharged on OPAT on the same antibiotic they received as inpatients. These findings suggest that new antibiotics looking to gain traction in the OPAT market must gain inclusion on hospital formularies and position themselves as preferred agents in the hospital setting.

Other key findings from the 2014 U.S. TreatmentTrends report entitled Hospital Discharge and Outpatient Parenteral Antimicrobial Therapy (OPAT):

  • ID specialists as key stakeholders in OPAT market: ID specialists are the healthcare providers most frequently involved in identifying a patient for discharge on OPAT; nearly three-quarters (72 percent) of surveyed ID specialists indicated that their hospital requires prior consultation with an ID specialist to evaluate and setup patients for OPAT.
  • Observation rooms/interim facilities for reducing hospital admissions: More than three quarters (82 percent) of surveyed ID specialists indicated that their hospital has facilities for keeping patients requiring short-term monitoring (less than 48 hours) without admitting them to the hospital. Over half of these facilities are used to administer IV antibiotics and can play an important role in decisions about whether to admi
    '/>"/>

SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
2. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
3. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
4. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
5. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
6. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
7. Applegate CEO Worries FDA Plan To Address Antibiotics In Animal Agriculture Is Too Little, Too Late
8. AVMA lauds FDA for new regulation of antibiotics in livestock feed
9. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
10. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
11. Antibiotic Resistance 2013: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Prepackaged Medical Kits and Trays - ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... for Prepackaged Medical Kits and Trays in US$ ... Trays, Ophthalmic Custom Trays, Custom Basin Kits, Custom ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2
... Club (FC) Barcelona, FC Barcelona Foundation, and ... three-year partnership today to energize the global fight to ... life-saving vaccines.  Bill Gates, co-chair of the Bill & ... Rosell and Manager Josep Guardiola, announced the partnership at ...
... this week at the American Association for Clinical Chemistry (AACC) ... and that testing individuals at risk may be beneficial. ... Health and Nutrition Survey, reported in the Archives of ... D levels over 30 nanogram/millilitre (ng/mL), a level that many ...
Cached Medicine Technology:Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 3
(Date:7/23/2014)... 23, 2014 Rich Dad® Education, a leader ... their charity yard sale to support Habit for Humanity of ... of the proceeds will be donated to Habitat for Humanity. ... being donated to the Habitat for Humanity ReStore thrift store ... , One of the highlights of the yard sale ...
(Date:7/23/2014)... 2014 Global Cardio Care, Inc., a ... Counterpulsation (EECP), is celebrating the 100th birthday of ... the health center. , Weber has been plagued ... ongoing EECP therapy since 1999, he no longer suffers ... of Global Cardio Care, introduced the Sara Soulati ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Bodybuilding.com, the ... online retailer of nutritional supplements, has officially opened the ... BPI SPORTS , the fastest growing sports nutrition company, ... , Brand of the Year, Best Tasting Protein of ... Protein Powder of the year - Whey-HD™, Pre-workout Supplement ...
(Date:7/23/2014)... treating the pernicious disorders of obesity and dementia reside ... University,s Center for Behavioral Neuroscience. In the paper, researchers ... at areas of the brain responsible for memory and ... play a role in reducing certain dementias., "In the ... often fall short. This is a new way for ...
(Date:7/23/2014)... Four hospitals affiliated with the Allegheny Health ... of the country’s best hospitals by U.S. News ... slated for publication in August, the U.S. News 2014-2015 ... Hospital, Saint Vincent Hospital and West Penn Hospital as ... , “There is no higher priority at Allegheny ...
Breaking Medicine News(10 mins):Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... Chem Rx (OTC,Bulletin Board: CHRX, CHRXU, CHRXW), a ... company ticker symbol has,changed to CHRX from PMQC. The ... trading community today., About Chem Rx Corporation, ... is a leading,provider of institutional pharmacy services in the ...
... SAN JOSE, Calif., April 18 VNUS(R) Medical,Technologies, Inc. ... has,received a Notice of Allowability by the U.S. Patent ... continuation of one of the three patents in,the VNUS ... The newly allowed VNUS patent application was filed as ...
... 18 AtriCure, Inc.,(Nasdaq: ATRC ), a medical device ... its financial results for the first quarter,ended March 31, 2008 ... conference call at 10:00 a.m. ET on Tuesday, May,6, 2008 ... of the,conference call will be available online from the investor ...
... connection between vitamin D level and the risk ... a long time, but its clinical relevance had ... from the working group headed by Dr. Jenny ... Krebsforschungszentrum, DKFZ), collaborating with researchers of the University ...
... LAKE CITY, April 18 Avalon Health Care, Inc. ... Lake City, Utah has,become the first skilled nursing facility ... Recognition (QRCR) from the American Association,for Respiratory Care (AARC)., ... by acute care,hospitals. This achievement reflects Avalon,s overall goal ...
... Changes in dopamine receptor density affects memory and psychomotor ... -- Long-term exposure to solvents in products such as ... the brain,s wiring, researchers report. , These abnormalities ... encephalopathy (CSE), the Dutch team conclude in the April ...
Cached Medicine News:Health News:Chem Rx Corporation Changes Ticker Symbol to CHRX 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 2Health News:U.S. Patent Office Allows Significant New VNUS Patent 3Health News:AtriCure Announces Web Cast and Conference Call of First Quarter 2008 Financial Results 2Health News:Vitamin D and breast cancer risk 2Health News:Woodland Park Care Center Earns Quality Respiratory Care Recognition 2Health News:Chronic Exposure to Solvents Disturbs Brain's Wiring 2
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
Bravo pH capsule with delivery system....
pH Calibration Stand with two Sealable Buffer Tubes 1 set....
... proper gel is essential in ... working with pH catheters with ... chloride ion concentration in the ... for proper function of your ...
Medicine Products: